Marked Chart Marked Chart Closed
Illustration for the Health desk

The stocks in this story

  1. NVO-1.4%Novo Nordisk A/S$38.87

Prices from Before the open · based on Thu close · Opens 9:30 AM ET. Each tile opens the stock's chart and news.

New to this? Read: Reading a stock chart

More Health news

Illustration for the Health desk

Biohaven

Biohaven shares phase 1 results for BHV-1530

Biohaven disclosed early trial data for its antibody-drug conjugate BHV-1530. The findings showed that patients with FGFR3-altered cancers experienced shrinkage of tumors and other clinical benefits.

Fast headlines, summarized. Not verified and not advice. Check the full story before you act.